Meglitinide (redirect from Glinide)
Meglitinides or glinides are a class of drugs used to treat type 2 diabetes. Repaglinide (trade name Prandin) gained US Food and Drug Administration approval...
4 KB (345 words) - 21:52, 3 April 2023
insulin, glinides, or sulfonylurea, who demonstrate Whipple's triad, it is reasonable to assume the cause of hypoglycemia is due to insulin, glinides, or sulfonylurea...
65 KB (6,264 words) - 23:47, 7 October 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
68 KB (5,684 words) - 19:57, 17 October 2024
treatment of type 2 diabetes. Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in...
3 KB (158 words) - 22:46, 3 April 2023
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
44 KB (3,492 words) - 21:58, 11 October 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
3 KB (184 words) - 13:53, 14 June 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
4 KB (328 words) - 05:24, 6 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
16 KB (1,542 words) - 20:53, 21 September 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
24 KB (1,877 words) - 07:44, 5 October 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
53 KB (4,975 words) - 03:43, 30 September 2024